Detalhe da pesquisa
1.
Amplification of the 9p13.3 chromosomal region in prostate cancer.
Genes Chromosomes Cancer
; 55(8): 617-25, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27074291
2.
Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers.
Prostate
; 74(16): 1647-54, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25252136
3.
The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers.
Genes Chromosomes Cancer
; 50(7): 499-509, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21472816
4.
Methods for identifying and studying genetic alterations in hormone-dependent cancers.
Methods Mol Biol
; 505: 263-77, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19117150
5.
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.
Clin Cancer Res
; 14(11): 3395-400, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18519769
6.
Clusterin is epigenetically regulated in prostate cancer.
Int J Cancer
; 123(7): 1601-9, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18649357
7.
CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.
Oncotarget
; 6(23): 19661-70, 2015 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25965834
8.
No amplifications of hypoxia-inducible factor-1alpha gene in invasive breast cancer: a tissue microarray study.
Cell Oncol
; 26(5-6): 347-51, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15623945
9.
Mapping of the chromosomal amplification 1p21-22 in bladder cancer.
BMC Res Notes
; 7: 547, 2014 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25135188
10.
Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer.
Cancer Epidemiol Biomarkers Prev
; 22(12): 2333-44, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24083995
11.
Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.
PLoS One
; 6(10): e26595, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22028916
12.
Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer.
Clin Cancer Res
; 16(10): 2845-51, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20442300
13.
Genetic aberrations in prostate cancer by microarray analysis.
Int J Cancer
; 119(6): 1322-9, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16642477
14.
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
Genes Chromosomes Cancer
; 45(7): 639-45, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16575874
15.
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
Am J Pathol
; 160(1): 339-45, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11786427